Astrana Health (NASDAQ:ASTH) Shares Gap Up on Analyst Upgrade

Shares of Astrana Health, Inc. (NASDAQ:ASTH) gapped up prior to trading on Wednesday after Robert W. Baird raised their price target on the stock from $67.00 to $86.00. The stock had previously closed at $42.91, but opened at $44.86. Robert W. Baird currently has an outperform rating on the stock. Astrana Health shares last traded at $44.39, with a volume of 50,865 shares changing hands.

A number of other equities research analysts have also issued reports on the company. Stifel Nicolaus increased their price target on Astrana Health from $48.00 to $60.00 and gave the company a “buy” rating in a research report on Thursday, August 1st. BTIG Research increased their price target on Astrana Health from $60.00 to $70.00 and gave the company a “buy” rating in a research report on Thursday, October 3rd. TD Cowen began coverage on Astrana Health in a research report on Monday, October 14th. They issued a “buy” rating and a $66.00 price target on the stock. KeyCorp began coverage on Astrana Health in a report on Friday, October 11th. They issued a “sector weight” rating on the stock. Finally, Truist Financial increased their price objective on Astrana Health from $50.00 to $59.00 and gave the company a “buy” rating in a report on Friday, August 9th. One research analyst has rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, Astrana Health presently has a consensus rating of “Buy” and an average price target of $65.17.

Institutional Trading of Astrana Health

Several hedge funds have recently modified their holdings of ASTH. GAMMA Investing LLC acquired a new stake in shares of Astrana Health in the 3rd quarter valued at approximately $34,000. Nisa Investment Advisors LLC acquired a new position in Astrana Health during the third quarter worth $35,000. KBC Group NV acquired a new position in Astrana Health during the third quarter worth $70,000. Quest Partners LLC acquired a new position in Astrana Health during the third quarter worth $133,000. Finally, Central Pacific Bank Trust Division acquired a new position in Astrana Health during the third quarter worth $160,000. 52.77% of the stock is owned by institutional investors and hedge funds.

Astrana Health Stock Performance

The firm has a fifty day moving average of $55.40 and a 200-day moving average of $47.72. The stock has a market capitalization of $2.19 billion, a price-to-earnings ratio of 33.16, a PEG ratio of 2.09 and a beta of 1.24. The company has a quick ratio of 1.84, a current ratio of 1.91 and a debt-to-equity ratio of 0.60.

Astrana Health (NASDAQ:ASTH) last announced its quarterly earnings data on Thursday, November 7th. The company reported $0.33 EPS for the quarter, meeting analysts’ consensus estimates of $0.33. The business had revenue of $478.71 million during the quarter, compared to the consensus estimate of $462.01 million. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. During the same quarter in the previous year, the business earned $0.47 earnings per share. As a group, sell-side analysts anticipate that Astrana Health, Inc. will post 1.12 EPS for the current year.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.